Transcarent
TR
Transcarent offers a health and care experience platform for employers. Members can get care navigation, virtual care, second opinions, and support for complex procedures. The service combines clinical guidance with benefit and pricing information to help people choose providers and manage care.
Founded by Glen Tullman (CEO), Lee Shapiro (Co-founder), Hemant Taneja (Co-founder)
Blended valuation$2B$2B secondary
Valuation history
Weekly blended valuation with priced funding rounds marked on the timeline.
$2.3B
blended valuationfunding round
Jan 10, 2022$1BSep 21, 2026
All rounds
6 funding rounds, newest first.
| Round | Announced | Raised | Post-money |
|---|---|---|---|
| Series D | Apr 8, 2025 | $481M | — |
| Series D | May 2, 2024 | $126M | $2.2B |
| Series D | Mar 25, 2024 | — | $2.1B |
| Series C | Jan 11, 2022 | $200M | $1.6B |
| Series B | Jun 10, 2021 | $58M | — |
Join Legion to view all 6 rounds.Sign in to Legion
Investors
20 investors across all rounds.
- GCGeneral Catalyst
- HCHuman Capital
- 7V7wire Ventures
- APAlta Partners
- TVThreshold Ventures
- ABAlly Bridge Group
- GCGeodesic Capital
- GVGreatPoint Ventures
- KIKinnevik
- MEMerck
Only Legion members can view the full investor roster. Sign in to Legion
Secondary market activity
Recent buy and sell interest for Transcarent shares on the secondary market.
| Kind | Implied valuation | Price / share | Date |
|---|---|---|---|
| $2B | $19.22 | Jun 24, 2026 | |
| $1.8B | $17.93 | Jun 5, 2026 |
Invest in the private markets on Legion
Registered users see full trading activity, every investor, rankings, and live deals.
Data as of Oct 16, 2026. Valuations are estimates blended from primary and secondary-market signals — not investment advice.